[EN] 2- [ (2-{PHENYLAMINO}-1H-PYRROLO [2, 3-D] PYRIMIDIN-4-YL) AMINO] BENZAMIDE DERIVATIVES AS IGF-1R INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE 2-[(2-{PHÉNYLAMINO}-1H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]BENZAMIDE EN TANT QU'INHIBITEUR D'IGF-1R POUR LE TRAITEMENT DU CANCER
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2009020990A1
公开(公告)日:2009-02-12
Novel pyrrolopyrimidines as shown in formula (I) and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
新型吡咯吡嘧啶如公式(I)所示,及其药用可接受的衍生物。这些化合物在抑制IGF-1R方面是有用的。
Imidazopyridine Kinase Inhibitors
申请人:Kuntz Kevin
公开号:US20080300242A1
公开(公告)日:2008-12-04
The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
本发明提供了咪唑并吡啶化合物、含有该化合物的组合物,以及它们的制备方法和作为药物的使用方法。
2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer
申请人:Chamberlain Stanley Dawes
公开号:US20100204196A1
公开(公告)日:2010-08-12
Novel pyrrolopyrimidines as shown in formula (I):
and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
式(I)所示的新型吡咯吡咪啉及其药学上可接受的衍生物。这些化合物在抑制IGF-1R方面是有用的。
Pyrimidine derivatives
申请人:Novartis AG
公开号:US07910585B2
公开(公告)日:2011-03-22
Novel pyrimidine derivatives of formula I
to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.